Publications:

1.       Bruce, A.G., and Uhlenbeck, O.C.  (1978)  Reactions at the Termini of tRNA with T4 RNA Ligase. Nucleic Acids Res. 5(10):3665-3677

2.       England, T.E., Bruce, A.G., and Uhlenbeck, O.C.  (1980) Specific Labeling of the 3’ Termini of RNA with T4 RNA Ligase. Methods in Enzymology 65(1):65-74

3.       Bruce, A.G., and Uhlenbeck, O.C.  (1982) Enzymatic Replacement of the Anticodon of Yeast Phenylalanine Transfer Ribonucleic Acid. Biochemistry 21(5):855-861

4.       Bruce, A.G., and Uhlenbeck, O.C.  (1982) Specific Interaction of the Anticodon Loop Residues with Yeast Phenylalanyl-tRNA Synthetase. Biochemistry 21(17):3921-3926

5.       Bruce, A.G., Atkins, J.F., Wills, N., Uhlenbeck, O.C., and Gesteland, R.F.  (1982)  Replacement of Anticodon Loop Nucleotides to Produce Functional tRNAs: Amber Suppressors Derived from Yeast tRNAPhe. Proc. Nat. Acad. Sci. USA 79(23):7127-7131

6.       Bruce, A.G., and Gesteland, R.F.  (1982) Properties of a Yeast tRNAPhe. Amber Suppressor. In: Interaction of Translational and Transcriptional Controls in the Regulation of Gene Expression. Eds. Grunberg-Manago, M., and Safer, B., Elsevier Biomedical, New York 203-213

7.       Bare, L., Bruce, A.G., Gesteland, R.F., and Uhlenbeck, O.C.  (1983) Uridine-33 in Yeast tRNA is not Essential for Amber Suppression. Nature 305:554-556

8.       Uhlenbeck, O.C., Bare, L., and Bruce, A.G.  (1984) Anticodon Substitutions in tRNA. In: Gene Expression, the Translational Step and its Control. Eds. Clark, B.F.C., and Petersen, H.U., Munksgaard, Copenhagen, 163-177

9.       Bruce, A.G., Atkins, J.F., and Gesteland, R.F.  (1986) tRNA Anticodon Replacement Experiments Show that Ribosomal Frameshifting can be Caused by Doublet Decoding. Proc. Nat. Acad. Sci. USA, 83:5062-5066

10.   Purchio, A.F., Twardzid, D.R., Bruce, A.G., Wizental, L., Madisen, L., Ranchalis, J.E., Hu, L.L., and Todaro, G.J.  (1987) Synthesis of an Active Hybrid Growth Factor in Bacteria: Transforming GF-alpha/Vaccinia GF Fusion Protein. Gene 60:175-182

11.   Rose, T.M., Bruce, A.G., Lee, J.J., Marvin, J.A., Grube, B.J., Heimbach, D.M., and Todaro, G.J.  (1990) Topical Application of Recombinant Vaccinia Growth Factor Enhances Healing in Partial Thickness Burns. J. Cellular Biochem. Supplement 14E-p.254

12.   Rose, T.M., and Bruce, A.G.  (1992) Oncostatin M is a Member of a Cytokine Family Which Includes Leukemia Inhibitory Factor, Granulocyte Colony-Stimulating Factor and Interleukin-6. Proc. Nat. Acad. Sci. USA 88:8641-8645

13.   Gearing, D.P., and Bruce, A.G.  (1992) Oncostatin M Binds the High-Affinity Leukemia Inhibitory Factor Receptor. The New Biologist 4:61-65

14.   Bruce, A.G., Hoggatt, I.H., and Rose, T.M.  (1992) Oncostatin M is a Differentiation Factor for Myeloid Leukemia Cells. J. Immunol. 149:1271-1275

15.   Kibblewhite, D.J., Bruce, A.G., Strong, D.M., Ott, S.M., Purchio, A.F., and Larrabee, W.F.  (1993) Transforming Growth Factor b1 Accelerates Osteoinduction in a Craniofacial Onlay Model. Growth Factors 9:185-193

16.   Rose, T.M., Weiford, D., Gunderson, N., and Bruce, A.G.  (1994) Oncostatin M Inhibits the Differentiation of Pluripotent Embryonic Stem Cells. Cytokine 6:48-54

17.   Jay, P.R., Centrella, M., Lorenzo, J., Bruce, A.G., and Horowitz, M.C.  (1996) Oncostatin-M: A New Bone Active Cytokine Which Activates Osteoblaasts and Inhibits Bone Resorption. Endocrinology 137:1151-1158

18.   Moxham, J.P., Kibblewhite, D.J., Bruce, A.G., Rigley, T., Gillespy, T., and Lane, J.  (1996) Transforming Growth Factor-b1 in a Guanidine-Extracted Demineralized Bone Matrix Carrier Rapidly Closes a Rabbit Critical Calvarial Defect. J. Otolaryngology, 25(2):82-87

19.   Nadler, S.G., Tritschler, D., Haffar, O.K., Blake, J., Bruce, A.G., and Cleaveland, J.S.  (1997) Differential Expression and Sequence Specific Interaction of Karyopherin a With Nuclear Localization Sequences. JBC, 272:4310-5.

20.   Haffar, O.K., Smithgall, M.D., Popov, S., Ulrich, P., Bruce, A.G., Nadler, S.G., Cerami, A., and Burkrinsky, M.I.  (1996) Nuclear Importation of the HIV-1 Genome in Activated Peripheral Blood Mononuclear Cells: A Prerequisite Step for Productive Infection. (submitted for publication)

21.   Bruce, A.G., A.M. Bakke, and T.M. Rose. (2005)  Development of a real-time Q-PCR assay for the detection of rhadinovirus-2 lineage-specific viruses in macaques and baboons.  Virology  Journal. 2, 2.

22.   Bielefeldt-Ohmann, H., Barouch, D.H., Bakke, A.M., Bruce, A.G., Durning, M., Grant, R., Letvin, N.L., Ryan, J.T., Schmidt, A., Thouless, M.E., and Rose, T.M. (2005)  Intestinal Stromal Tumors in a SIV-infected, SRV-2 negative, rhesus macaque (Macaca mulatta)  Veterinary Pathology 42: 391-396.

23.   Philipp-Staheli, J., Marquardt, T., Thouless, M.E., Bruce, A.G., Grant, R.F., Tsai, C.-C., and Rose, T.M. (2006)  Genetic variability of the envelope gene of Type D simian retrovirus-2 (SRV-2) subtypes associated with SAIDS-related retroperitoneal fibromatosis in different macaque species.  Virol. J. 3, 11.

24.   Burnside, K.L., Ryan, J.T., Bielefeldt-Ohmann, H., Bruce, A.G.,Thouless, M.E., Tsai, C.-C. and Rose, T.M.  (2006)  RFHVMn ORF73 is Structurally Related to the KSHV ORF73 Latency-Associated Nuclear Antigen (LANA) and is Expressed in Retroperitoneal Fibromatosis (RF) Tumor Cells.  Virology, 354, 103-115.

25.   Bruce, A.G., Bakke, A.M., Bielefeldt-Ohmann, H., Ryan, J.T., Thouless, M.E., Tsai, C.-C., and Rose, T.M. (2006) High levels of RFHV in retroperitoneal fibromatosis (RF) lesions are associated with ORF73 LANA expression. J Gen Virol 87, 3529-3538